Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.9K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Neural Regulation01:37

Neural Regulation

40.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.7K
Drug Regulation01:25

Drug Regulation

2.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.2K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

304
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
304
Pharmacovigilance01:19

Pharmacovigilance

1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
Global Regulatory Systems01:28

Global Regulatory Systems

221
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
221

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate justice as a public health imperative: a perspective from Sierra Leone considering the 2025 International Court of Justice opinion.

Infectious diseases of poverty·2026
Same author

Human deskilling in medical artificial intelligence: prohibited or permissible under the EU Artificial Intelligence Act?

Nature reviews. Gastroenterology & hepatology·2026
Same author

Utah's Prescription-Renewal Pilot Program - Autonomous AI Managing Patient Care.

The New England journal of medicine·2026
Same author

Innovation and policy challenges of AI-drug hybrids.

Nature biotechnology·2026
Same author

From AI SIM to AI twinning: a spectrum of digital representations of persons.

Journal of medical ethics·2026
Same author

Medicare advantage becoming a disadvantage with use of artificial intelligence in prior authorization review.

NPJ digital medicine·2026

Related Experiment Video

Updated: Oct 30, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Regulatory responses to medical machine learning.

Timo Minssen1, Sara Gerke2, Mateo Aboy3

  • 1Centre for Advanced Studies in Biomedical Innovation Law, Copenhagen, Denmark.

Journal of Law and the Biosciences
|July 5, 2021
PubMed
Summary

Medical machine learning (MML) aids clinical decisions but faces regulatory hurdles. This study analyzes US and EU approaches to MML device evaluation and international considerations for safe implementation.

Keywords:
artificial intelligenceethicsmedical devicesmedical machine learningregulation

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.1K

Related Experiment Videos

Last Updated: Oct 30, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.1K

Area of Science:

  • Medical Artificial Intelligence (AI)
  • Machine Learning (ML) in Healthcare
  • Regulatory Science

Background:

  • Healthcare is increasingly adopting medical artificial intelligence (AI), specifically medical machine learning (MML).
  • MML utilizes machine learning (ML) algorithms to analyze medical data for clinical decision support.
  • Key challenges include regulatory evaluation of MML device safety and effectiveness, and international considerations.

Purpose of the Study:

  • To analyze current regulatory frameworks for MML in the USA and Europe.
  • To examine international perspectives and broader implications of MML implementation.
  • To identify critical considerations for the safe and effective global use of MML.

Main Methods:

  • Comparative analysis of regulatory approaches to MML in the USA and Europe.
  • Examination of international viewpoints on MML adoption.
  • Discussion of specific MML considerations: data privacy, bias, and transparency.

Main Results:

  • Current regulatory strategies in the USA and Europe for MML devices are being established.
  • International perspectives highlight the need for harmonized approaches to MML.
  • Significant considerations include data privacy, bias in training data, and the need for explainability.

Conclusions:

  • Regulatory evaluation of MML medical devices requires careful consideration of safety and effectiveness.
  • International collaboration is crucial for addressing global MML challenges like data privacy and bias.
  • Addressing issues such as training set bias, contextual bias, and trade secrecy is vital for responsible MML deployment.